Brief Report: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Posted on by

New England Journal of Medicine
January 21, 2021 Vol. 384 No. 3
http://www.nejm.org/toc/nejm/medical-journal

 

Brief Report: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia – H. Frangoul and Others